Order Restylane® Lyft w/ Lidocaine for Clinics

Restylane® Lyft w/ Lidocaine is a sterile injectable hyaluronic acid gel supplied in a 1 mL prefilled glass syringe for professional aesthetic use. Licensed clinics, med spas, and healthcare professionals can order it for controlled treatment-room workflows that require a structured HA filler with lidocaine. Each unit contains stabilized hyaluronic acid 20 mg/mL with lidocaine hydrochloride 3 mg/mL and includes two sterile needles.

This filler is used by trained injectors for volume support, contouring, and soft-tissue augmentation in appropriate dermal or subcutaneous planes. The integrated anesthetic supports procedural comfort, while the ready-to-use syringe helps reduce preparation steps during busy clinic sessions. Med Wholesale Supplies serves licensed professional accounts with brand-name medical products sourced through vetted distributor channels and verified supply routes.

Wholesale Price, Account Access, and Pack Details

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account. Pricing can vary by order size, account profile, and purchasing cadence, so the live account portal is the best source for current cost information. Professional ordering requirements may apply before clinic-level purchasing is enabled.

The supplied configuration is a Restylane Lyft with Lidocaine 1 mL syringe in a sterile presentation. Pack composition includes one 1 mL prefilled glass syringe, two sterile needles, hyaluronic acid 20 mg/mL, and lidocaine hydrochloride 3 mg/mL. The product is intended for single-use professional administration and should be handled according to the manufacturer’s instructions and your facility’s injection protocols.

Quick tip: Match reorder quantities to scheduled procedure volume, lot rotation, and injector preference rather than stocking filler by brand alone.

How Clinics Use This HA Filler

Restylane® Lyft w/ Lidocaine is a transparent, biodegradable, non-animal stabilized hyaluronic acid gel. Clinics use this type of filler when treatment planning calls for lift, projection, or contour support rather than only fine-line correction. The gel is injected by trained clinicians into the appropriate plane based on the treatment area, product labeling, anatomy, and clinic policy.

Common professional workflows include midface structure, cheek definition, and hand volume support. Authoritative labeling also describes use for correction of moderate to severe facial folds and wrinkles, such as nasolabial folds, and certain augmentation applications under professional administration. Patient selection, informed consent, vascular anatomy knowledge, and complication readiness remain central to safe use.

For broader treatment planning within this product family, clinics can reference the Restylane treatment guide. Practices comparing HA filler positioning may also find the Juvederm Ultra 4 and Restylane Lyft comparison useful when building protocols for different tissue needs.

Active Ingredients and Handling Characteristics

The active composition is hyaluronic acid 20 mg/mL with lidocaine hydrochloride 3 mg/mL. Hyaluronic acid is a naturally occurring polysaccharide used in dermal fillers because it can bind water and support soft-tissue volume. Lidocaine is an amide-type local anesthetic included to help reduce discomfort during injection.

The gel is transparent, stabilized, biodegradable, and non-animal in origin. Contents are sterilized by moist heat and supplied in a prefilled glass syringe to support aseptic treatment-room handling. Lot and expiry information should be recorded according to clinic documentation procedures, especially when multiple injectors or multiple rooms share central inventory.

Workflow Benefits for Licensed Practices

A prefilled syringe reduces product preparation steps and helps keep the injection setup consistent across treatment rooms. The included needles limit extra supply pulls, which can improve room turnover and support standardized procedure trays. Consistent extrusion and a clear gel matrix may help injectors maintain controlled, measured placement during aesthetic correction.

The lidocaine component can reduce the need for separate anesthetic measures in many protocols, although clinics should still follow their own comfort, consent, and monitoring policies. Because this is a single-use sterile presentation, staff should avoid reprocessing, sharing, or saving partially used material. Dispose of sharps and remaining material according to facility rules and applicable biomedical waste procedures.

For more context on the role of anesthetic-containing fillers, see the clinic-focused discussion of lidocaine in dermal filler procedures. To browse adjacent products in the same brand family, use the Restylane brand category.

Safety, Contraindications, and Professional Precautions

Dermal filler administration requires appropriate training, anatomical knowledge, and a plan for managing adverse events. Common reactions are usually localized and transient, and may include pain, itching, tenderness, edema, localized swelling, bruising, discoloration, and headache. Clinics should counsel recipients on expected post-procedure reactions and document aftercare instructions according to internal policy.

Contraindications include bleeding disorders and known hypersensitivity to amide-type local anesthetics such as lidocaine. Use should be deferred when relevant allergies, active infection at the treatment site, or other contraindicating conditions are identified by the treating clinician. Product placement, injection volume, and technique should be determined by the injector’s assessment and current labeling.

Serious complications are uncommon but can occur with injectable fillers, including vascular compromise, tissue injury, infection, nodules, inflammatory reactions, or unintended material placement. Clinics should maintain emergency protocols, appropriate supplies, and escalation pathways for suspected vascular events or other urgent complications. Any unexpected or severe reaction should be assessed promptly by a qualified healthcare professional.

Why it matters: The same sterile syringe can support efficient workflow only when staff also maintain strict aseptic technique and traceability.

Storage, Inventory, and Logistics

Store and handle Restylane® Lyft w/ Lidocaine according to the manufacturer’s insert and clinic inventory policy. Keep units in original packaging until use, protect sterility, and verify lot number and expiry before the syringe enters the treatment room. Rotate stock so earlier-dated units are used first, and separate any damaged or questionable packaging from active inventory.

For multi-site practices, central purchasing can help standardize product selection, documentation, and reorder thresholds across locations. Bulk order planning should reflect actual treatment demand, injector utilization, and remaining shelf life. Temperature-controlled handling when required and tracked US delivery can be coordinated as part of routine professional logistics.

Clinics building complete injection workflows may also evaluate compatible supplies and adjacent medical products through established internal purchasing standards. Avoid substituting fillers solely because they share an HA base; rheology, intended plane, treatment objective, and injector familiarity all affect product selection.

How It Compares Within the Restylane Family

Restylane Lyft with Lidocaine is not the same as Restylane with Lidocaine. Both are hyaluronic acid fillers with lidocaine, but they are positioned for different clinical uses and handling characteristics. Restylane Lyft is commonly selected when structural support, projection, or contouring is required, while classic Restylane preparations are often used for different correction needs within the same HA family.

For clinics that need a related HA option, Restylane 1 mL with Lidocaine may fit protocols focused on other line or fold indications. Practices that prefer the same product without lidocaine can review Restylane Lyft 1 mL. For robust volumizing needs, Restylane Volyme with Lidocaine may be considered according to injector preference and labeling.

When comparing fillers across manufacturers, evaluate intended treatment area, gel behavior, injection plane, adverse-event profile, clinic training, and patient-specific risks. A broader discussion of two leading HA filler families is available in the Restylane and Juvederm comparison.

Ordering Notes for Professional Accounts

If your practice operates multiple sites, align the order with treatment calendars, standing par levels, and lot-tracking expectations before submitting replenishment.

Restylane Lyft with Lidocaine wholesale purchasing is best managed through a defined formulary or product matrix. That approach helps staff understand which filler is used for each protocol, how substitutions are approved, and which injectors are trained on each product. Procurement teams should also maintain manufacturer inserts, lot records, and internal handling instructions where staff can access them.

If a preferred unit is temporarily constrained, a clinical lead should approve any functional alternative before it is added to procedure rooms. Substitution decisions should consider more than ingredient class; texture, projection, labeled use, and treatment objective can differ between HA fillers.

Authoritative Sources

• Restylane Lyft instructions for use
• Manufacturer Restylane Lyft information
• FDA dermal filler safety information

This content is for informational purposes only and is not a substitute for professional medical advice.